Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
02/27/2003 | US20030040481 Contacting a tissue factor(TF)-expressing cell with a motility modifying-effective amount of a compound selected from the group consisting of Factor VIIa; a Factor VIIa agonist; and a Factor VIIa antagonist for modifying cell motility |
02/27/2003 | US20030040476 EAG gene |
02/27/2003 | US20030040473 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030040466 Identifying peptide of interest; preparing peptide to be coupled to a sensor; preparing sensor to be coupled to peptide; coupling peptide to sensor; quantifying signal output from sensor; exposing sensor ligands; quantifying signal |
02/27/2003 | US20030040461 Providing a cell expressing Bruton's Tyrosine Kinase; contacting cell expressing Bruton's Tyrosine Kinase with a test compound; determining whether test compound modulates the activity of Bruton's Tyrosine Kinase |
02/27/2003 | US20030040292 Local oscillator leakage control in direct conversion processes |
02/27/2003 | US20030040129 Binding assays using magnetically immobilized arrays |
02/27/2003 | US20030040128 Conducting, recording and evaluating particle screening test; obtain sample, incubate with solid support, electronically image, record image |
02/27/2003 | US20030040127 Multiple epitopes connected by a carrier |
02/27/2003 | US20030040126 Immunological test kit with immunologically invisible carrier |
02/27/2003 | US20030040125 Methods for performing immunological assays |
02/27/2003 | US20030040124 Paramagnetism particles; opacity coverings; quantative analysis |
02/27/2003 | US20030040122 Instruments for measuring the total organic carbon content of water |
02/27/2003 | US20030040121 Compositon for use in the detection of trichloroethylene |
02/27/2003 | US20030040120 Systems and methods for measuring nitrate levels |
02/27/2003 | US20030040119 Separation of preferential particles; obtain sample, insert into analyzer, detect preferential particles |
02/27/2003 | US20030040116 Catalytic testing device and method for its use in material testing |
02/27/2003 | US20030040115 Lytic reagent composition for determination of nucleated red blood cells |
02/27/2003 | US20030040109 Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts |
02/27/2003 | US20030040106 Apparatus for use in the detection of preferential particles in solution |
02/27/2003 | US20030040105 Microfluidic micromixer |
02/27/2003 | US20030040096 Nucleotide sequences coding enzmatic polypeptide for use in the treatment of acquired immunodeficiency syndromes, nervous system and ischemic injury disorders |
02/27/2003 | US20030040088 Protein for use in the treatment of immune, blood, gastrointestinal, and cancer disorders |
02/27/2003 | US20030040087 Method for arraying biomolecules and for monitoring cell motility in real-time |
02/27/2003 | US20030040083 Dual specificity antibodies and methods of making and using |
02/27/2003 | US20030040081 Galectin 9 and 10SV polynucleotides |
02/27/2003 | US20030040078 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
02/27/2003 | US20030040076 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030040071 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
02/27/2003 | US20030040054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030040053 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders and tumors |
02/27/2003 | US20030040052 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of human cancers |
02/27/2003 | US20030040051 Wnt receptor compositions and methods |
02/27/2003 | US20030040050 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |
02/27/2003 | US20030040048 Nucleotide sequences coding polypeptide for use in the treatment of cancer, heart and viral diseases |
02/27/2003 | US20030040046 Netrin receptors |
02/27/2003 | US20030040045 Mammalian sweet taste receptors |
02/27/2003 | US20030040044 Anti-dual integrin antibodies, compositions, methods and uses |
02/27/2003 | US20030040041 Nucleotide sequences coding polypeptide for use in the treatment of scarring and/or fibrosis |
02/27/2003 | US20030040039 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
02/27/2003 | US20030040038 Screening effect of modulators on target cells; obtain cell, transform with expresion vector coding activator and preferential protein, monitor cell activity, compare to control |
02/27/2003 | US20030040036 Synovial fluid control |
02/27/2003 | US20030040033 Kit for use in monitor and analyzing cell migration |
02/27/2003 | US20030040031 Apparatus for monitoring cell migration |
02/27/2003 | US20030040030 Homocysteine assay |
02/27/2003 | US20030040028 Analgesic screening method and composition |
02/27/2003 | US20030040027 Method for determining protein component in a biological sample |
02/27/2003 | US20030040026 Isolation of membrane bound ligand-specific complexes |
02/27/2003 | US20030040025 Evaluating immunotoxicity of hydrophobic test substance; obtain cells, propagate in nutrient broths, monitor viability, incubate with modulator, monitor viabilty, compare adjustments in viability |
02/27/2003 | US20030040024 Method and kit for the diagnosis of troponin I |
02/27/2003 | US20030040023 Isolation of neural stem cells using gangliosides and other surface markers |
02/27/2003 | US20030040021 Apparatus for use in the detection of preferential particles in sample |
02/27/2003 | US20030040020 Assay system for simultaneous detection and measurement of multiple modified cellular proteins |
02/27/2003 | US20030040019 Biological material chip |
02/27/2003 | US20030040018 Detecting bone density reduction; obtain tissue sample, measure concentration of bone marker protein, compare to control, evaluate for reduction in bone density |
02/27/2003 | US20030040016 Analyzing phosphorylated proteins |
02/27/2003 | US20030040014 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030040013 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030040012 Method of detecting protein-protein interaction |
02/27/2003 | US20030040009 Saliva-based methods for preventing and assessing the risk of diseases |
02/27/2003 | US20030040008 Immobilization of preferential particles on solid support; generate solid support, incubate with reactive cyclodextrin, join cyclodextrin to solid support, expose to preferential particle, join to cyclodextrin support |
02/27/2003 | US20030040004 Coplanar waveguide biosensor for detecting molecular or cellular events |
02/27/2003 | US20030040003 Detection of mutation in preferential nucleotide sequences; obtain cells, fuse, recover hybrids, monitor gene activity in hybrids, detect aberrant gene activity |
02/27/2003 | US20030040001 LETM1: modulators of cellular proliferation |
02/27/2003 | US20030040000 Methods for attaching nucleic acid molecules to electrically conductive surfaces |
02/27/2003 | US20030039999 B7 related protein-2 molecules and uses thereof |
02/27/2003 | US20030039998 Evaluating tumor propagation in humans; obtain tissue sample, monitor cyclin dependent kinase expression and activity, compare to control, amplified kinase activity and expression indicates cancer |
02/27/2003 | US20030039997 Pentopyranosyl nucleic acid arrays, and uses thereof |
02/27/2003 | US20030039993 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of cancer |
02/27/2003 | US20030039990 Expression vector for use as gene transfer tool ingenetic engineering |
02/27/2003 | US20030039987 Defects in periaxin associated with myelinopathies |
02/27/2003 | US20030039986 Compositions and methods relating to prostate specific genes and proteins |
02/27/2003 | US20030039983 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer |
02/27/2003 | US20030039981 Probes for use as diagnostic tools in the detection of parasites |
02/27/2003 | US20030039980 Evaluating receptor protein response to modulator; obtain protein sample, incubate with modulator, monitor binding activity and complex formation, adjustment binding activity and complex formation indicates modulators |
02/27/2003 | US20030039972 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030039971 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
02/27/2003 | US20030039970 Diagnosing cancer in humans; obtain tissue sample, determine concentration of calreticulin in sample, compare to control, evaluate for cancer |
02/27/2003 | US20030039969 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030039966 Genetic engineering; bone disorders |
02/27/2003 | US20030039963 Detecting bactericides; obtain nucleotide sequences, screen library, detect fit, evaluate protein for bactericidal activity |
02/27/2003 | US20030039961 Nucleic acid sequence detection employing amplification probes |
02/27/2003 | US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer |
02/27/2003 | US20030039958 Screening polypeptides pool to detect preferential polypeptide activity; immobilize target nucleotide sequences on microarray, express nucleotide sequences, recover protein, interact with preferential polypeptide, monitor activity |
02/27/2003 | US20030039957 Functional protein expression for rapid cell-free phenotyping |
02/27/2003 | US20030039954 Viral nucleotide sequences for use in the diagnosis, prevention and treatment of viral diseases |
02/27/2003 | US20030039737 Population of dairy cows producing milk with desirable characteristics and methods of making and using same |
02/27/2003 | US20030039725 System and method of leavening with carbon dioxide monitoring |
02/27/2003 | US20030039693 Three-dimensional biocatalyst |
02/27/2003 | US20030039664 Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting |
02/27/2003 | US20030039663 Vaccine; neutralizing antibodies; detecting infections |
02/27/2003 | US20030039649 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences |
02/27/2003 | US20030039648 Compositions and methods for the diagnosis and treatment of tumor |
02/27/2003 | US20030039632 Novel bacteriocins, transport and vector system and method of use thereof |
02/27/2003 | US20030039611 Selectively binds to antigen to cause cell impairment |
02/27/2003 | US20030039584 Device for removing consumable analytic products from a storage container |
02/27/2003 | US20030039384 Method and apparatus for processing an image of a tissue sample microarray |
02/27/2003 | US20030039299 Sensor device and method for qualitative and quantitative analysis of gas phase substances |
02/27/2003 | US20030038828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
02/27/2003 | US20030038827 Secreted and transmembrane polypeptides and nucleic acids encoding the same |